1.Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
Hausenblas, Heather Ann ; Saha, Debbie ; Dubyak, Pamela Jean ; Anton, Stephen Douglas
Journal of Integrative Medicine 2013;11(6):377-83
Due to safety concerns and side effects of many antidepressant medications, herbal psychopharmacology research has increased, and herbal remedies are becoming increasingly popular as alternatives to prescribed medications for the treatment of major depressive disorder (MDD). Of these, accumulating trials reveal positive effects of the spice saffron (Crocus sativus L.) for the treatment of depression. A comprehensive and statistical review of the clinical trials examining the effects of saffron for treatment of MDD is warranted.
2.Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
Heather Ann HAUSENBLAS ; E-mail: HHAUSEN@JU.EDU. ; Debbie SAHA ; Pamela Jean DUBYAK ; Stephen Douglas ANTON
Journal of Integrative Medicine 2013;11(6):377-383
BACKGROUNDDue to safety concerns and side effects of many antidepressant medications, herbal psychopharmacology research has increased, and herbal remedies are becoming increasingly popular as alternatives to prescribed medications for the treatment of major depressive disorder (MDD). Of these, accumulating trials reveal positive effects of the spice saffron (Crocus sativus L.) for the treatment of depression. A comprehensive and statistical review of the clinical trials examining the effects of saffron for treatment of MDD is warranted.
OBJECTIVEThe purpose of this study was to conduct a meta-analysis of published randomized controlled trials examining the effects of saffron supplementation on symptoms of depression among participants with MDD.
SEARCH STRATEGYWe conducted electronic and non-electronic searches to identify all relevant randomized, double-blind controlled trials. Reference lists of all retrieved articles were searched for relevant studies.
INCLUSION CRITERIAThe criteria for study selection included the following: (1) adults (aged 18 and older) with symptoms of depression, (2) randomized controlled trial, (3) effects of saffron supplementation on depressive symptoms examined, and (4) study had either a placebo control or antidepressant comparison group.
DATA EXTRACTION AND ANALYSISUsing random effects modeling procedures, we calculated weighted mean effect sizes separately for the saffron supplementation vs placebo control groups, and for the saffron supplementation vs antidepressant groups. The methodological quality of all studies was assessed using the Jadad score. The computer software Comprehensive Meta-analysis 2 was used to analyze the data.
RESULTSBased on our pre-specified criteria, five randomized controlled trials (n = 2 placebo controlled trials, n = 3 antidepressant controlled trials) were included in our review. A large effect size was found for saffron supplementation vs placebo control in treating depressive symptoms (M ES = 1.62, P < 0.001), revealing that saffron supplementation significantly reduced depression symptoms compared to the placebo control. A null effect size was evidenced between saffron supplementation and the antidepressant groups (M ES = -0.15) indicating that both treatments were similarly effective in reducing depression symptoms. The mean Jadad score was 5 indicating high quality of trials.
CONCLUSIONFindings from clinical trials conducted to date indicate that saffron supplementation can improve symptoms of depression in adults with MDD. Larger clinical trials, conducted by research teams outside of Iran, with long-term follow-ups are needed before firm conclusions can be made regarding saffron's efficacy and safety for treating depressive symptoms.
Crocus ; adverse effects ; Depressive Disorder, Major ; drug therapy ; Humans ; Phytotherapy ; Randomized Controlled Trials as Topic
3.Effect of a novel dietary supplement on pH levels of healthy volunteers: a pilot study.
Stephen Douglas ANTON ; E-mail: SANTON@UFL.EDU. ; Xiaomin LU ; Ginny BANK ; Kacey HEEKIN ; Debbie SAHA ; Pamela J DUBYAK ; Heather Ann HAUSENBLAS
Journal of Integrative Medicine 2013;11(6):384-388
OBJECTIVETo examine the effects of a greens alkalizing dietary supplement on urinary pH levels in individuals with lower-than-average pH levels.
METHODSThe present study investigated the effects of an alkalizing formula (Reserveage Wholeganic Greens(TM)) on four individuals who had average urinary pH levels below 6.0 for three consecutive days. Following the three-day, baseline period, participants received Reserveage Wholeganic Greens(TM) for four consecutive days and were instructed to continue to measure their urine pH levels. Paired samples t-tests were used to examine pH levels before and after a four-day treatment period with Reserveage Wholeganic Greens(TM).
RESULTSCompared to baseline, mean urine pH levels in all volunteers were significantly higher following the supplementation with Reserveage Wholeganic Greens(TM) (5.89 ± 0.20 vs 5.56 ± 0.23; P<0.01). Participants' pH levels were also significantly higher than baseline on days 5, 6, and 7 of the treatment period (P < 0.05). Noteworthy, on day 7, participants' mean pH levels were significantly higher than at the beginning of the treatment period (6.03 ± 0.15 at day 7 vs 5.65 ± 0.24 at day 4; P < 0.01).
CONCLUSIONThe findings of this study suggest that supplementation with Reserveage Wholeganic Greens(TM) has an alkalizing effect on the body and can increase the urine pH levels in individuals with lower-than-average pH levels.
Adult ; Dietary Supplements ; Edible Grain ; Female ; Healthy Volunteers ; Humans ; Hydrogen-Ion Concentration ; Male ; Middle Aged ; Pilot Projects ; Poaceae ; Vegetables